The University of Washington was awarded a $1,256,015.00 federal contract by the Centers for Disease Control and Prevention (CDC) to conduct a prospective observational cohort study of household transmission of COVID-19 in Seattle, Washington. This definitive cost-type contract has a completion date of January 1, 2022 and does not have a set-aside designation. Through this contract, the University of Washington will provide research services to the CDC to investigate the spread of COVID-19...
The University of Washington Office of Sponsored Programs Division, doing business as Grant & Contracts Division, was awarded a definitive cost-no-fee contract valued at approximately $1.6 million by the Centers for Disease Control and Prevention to support BAA NO. 170 regarding COVID-19 prevalence, household transmission, and antibody research. As the prime contractor, the University of Washington will leverage its expertise and resources in Seattle, Washington to conduct epidemiological...
This is a $3,502,329.47 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) on September 30, 2014 for "Other Functions" with an ultimate completion date of September 30, 2019. The contract has a cost-no-fee pricing type and is not set aside for small businesses. UW is a large educational institution that has a history of providing a range of research, medical, and technical services to various federal agencies through...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $662,635.00 definitive contract to the University of Washington for host-pathogen discovery research under Broad Agency Announcement 279 Topic 6. The contract is a cost-no-fee arrangement with a completion date of December 19, 2024. The place of performance is Seattle, Washington. The University of Washington is a public research university that has received numerous prime federal contracts and...
This is a $647,776.00 firm fixed price definitive contract awarded to the University of Washington (UW) by the Centers for Disease Control and Prevention (CDC) for KAER services. The contract has an ultimate completion date of December 31, 2024 and was awarded on September 30, 2022 with no set-aside designation. UW is a leading research university that frequently secures federal contract and grant awards to provide a range of goods and services to civilian and defense agencies. This contract...
This is a federal contract award to the University of Washington (UW) by the Centers for Disease Control and Prevention (CDC) for $742,701.15. The contract, which does not have a set-aside designation, is for FY 2021 BAA TOPIC 8 - WASHINGTON and has an ultimate completion date of February 14, 2022. UW, a leading research university, is delivering viral genome sequencing and open-source software development services to support genetic epidemiology in Washington State through a subcontract with...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for Sexually Transmitted Infections Impact Research Consortium Support Services. The contract has a ceiling value of $10,011,255.33 and a period of performance through April 2025. The contract is not set aside for any specific business type. UW, as a prominent research university, will provide a variety of scientific, medical, and technological services to...
This is a $116,276.26 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Washington for unspecified "other functions" with no set-aside designation. The University of Washington is a leading public research university that has received numerous prime federal contracts and grants to provide a range of research, technical, and healthcare services across various federal agencies. While...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to the University of Washington (UW) for non-medical cost estimates and injury morbidity services. The contract has a ceiling value of $242,281.00 and a performance period ending on August 30, 2024. The contract is not set aside for any socioeconomic categories. UW is a large public research university that frequently secures prime federal contracts and grants...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW). The contract, valued at $7,822,728.37, is for biomedical research services under the Population Genetics Analysis Program. The contract is a definitive, cost-no-fee type and does not have a set-aside designation. UW is a leading public research university that has extensive experience in supporting federal agencies through prime contract and grant...